News 2018-09-18T15:06:26+00:00

3 Reasons The Health AI Market is a Great Investment: PrecisionMedicine using Genetic Signature Targeting – Arun Asaithambi Co-founder of Lantern Pharma Inc is featured in

TiE Announces AI Driven Lantern Pharma as 2018 Top 50 Emerging Company
Lantern Pharma is excited to announce that it has been selected as a “2018 TiE50 winner” for the prestigious TiE50 Awards Program recognizing the world’s most innovative tech startups. This awards competition is part of TiE Inflect 2018, the world’s largest conference for tech entrepreneurs
Business Wire

Precision Oncology Company Lantern Pharma to Showcase Artificial Intelligence Approach

Lantern Pharma Joins Genomics England to Advance Their Precision Oncology Platform